Petros Pharmaceuticals, Inc. Quarterly Return On Equity in % from Q4 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Petros Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q3 2024.
  • Petros Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was -57.2 %, a 41.4% increase year-over-year.
  • Petros Pharmaceuticals, Inc. annual Return On Equity for 2023 was -68.9 %, a 7.73% increase from 2022.
  • Petros Pharmaceuticals, Inc. annual Return On Equity for 2022 was -74.7 %, a 94.9% decline from 2021.
  • Petros Pharmaceuticals, Inc. annual Return On Equity for 2021 was -38.3 %, a 96.1% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -57.2 +40.4 +41.4% Jul 1, 2024 Sep 30, 2024
Q2 2024 -76.6 +57.1 +42.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 -85.7 +11.9 +12.2% Jan 1, 2024 Mar 31, 2024
Q4 2023 -68.9 +5.77 +7.73% Oct 1, 2023 Dec 31, 2023
Q3 2023 -97.7 -21.6 -28.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 -134 -95.2 -247% Apr 1, 2023 Jun 30, 2023
Q1 2023 -97.6 -52.8 -118% Jan 1, 2023 Mar 31, 2023
Q4 2022 -74.7 -36.4 -94.9% Oct 1, 2022 Dec 31, 2022
Q3 2022 -76.1 -43.1 -131% Jul 1, 2022 Sep 30, 2022
Q2 2022 -38.5 +23.3 +37.7% Apr 1, 2022 Jun 30, 2022
Q1 2022 -44.8 +123 +73.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 -38.3 +936 +96.1% Oct 1, 2021 Dec 31, 2021
Q3 2021 -33 Jul 1, 2021 Sep 30, 2021
Q2 2021 -61.8 Apr 1, 2021 Jun 30, 2021
Q1 2021 -168 Jan 1, 2021 Mar 31, 2021
Q4 2020 -975 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.